Anti-IL-6
Encyclopedia
Anti-interleukin-6 agents are a recent class of therapeutics.
Interleukin-6 is relevant to many inflammatory diseases and many cancers. Hence anti-IL-6 agents have been sought.
The first approved, tocilizumab
(Actemra), actually acts against the IL-6 receptor.
In clinical trials : Elsilimomab
for some cancers, Anti-IL-6 chimeric monoclonal antibody
(CNTO 328), ALD518
, CNTO 136, CPSI-2364, CDP6038.
Pre-clinical : VX30 for rheumatoid arthritis
. Also ARGX-109, FE301,
FM101
.
Luteolin
reduces IL-6 production in some neurons.
Interleukin-6 is relevant to many inflammatory diseases and many cancers. Hence anti-IL-6 agents have been sought.
The first approved, tocilizumab
Tocilizumab
Tocilizumab is an immunosuppressive drug, mainly for the treatment of rheumatoid arthritis and systemic juvenile idiopathic arthritis, a severe form of RA in children. It is a humanized monoclonal antibody against the interleukin-6 receptor...
(Actemra), actually acts against the IL-6 receptor.
In clinical trials : Elsilimomab
Elsilimomab
Elsilimomab is a mouse monoclonal antibody and an immunosuppressive drug.It targets Interleukin-6.It has undergone a number of early stage clinical trails, eg. for lymphoma and myeloma....
for some cancers, Anti-IL-6 chimeric monoclonal antibody
Anti-IL-6 chimeric monoclonal antibody
CNTO 328 is a chimeric monoclonal antibody being studied in the treatment of advanced kidney cancer and other types of cancer....
(CNTO 328), ALD518
ALD518
BMS-945429 is an aglycosylated, humanized monoclonal antibody against interleukin-6. It is an investigational drug for cancer and rheumatoid arthritis due to its anti-inflammatory properties....
, CNTO 136, CPSI-2364, CDP6038.
Pre-clinical : VX30 for rheumatoid arthritis
Rheumatoid arthritis
Rheumatoid arthritis is a chronic, systemic inflammatory disorder that may affect many tissues and organs, but principally attacks synovial joints. The process produces an inflammatory response of the synovium secondary to hyperplasia of synovial cells, excess synovial fluid, and the development...
. Also ARGX-109, FE301,
FM101
Food/diet
It has been reported that lunasin, a soy peptide, reduces inflammation by reducing interleukin-6 and may help in leukemiaLeukemia
Leukemia or leukaemia is a type of cancer of the blood or bone marrow characterized by an abnormal increase of immature white blood cells called "blasts". Leukemia is a broad term covering a spectrum of diseases...
.
Luteolin
Luteolin
Luteolin is a yellow crystalline compound. It is a flavonoid; to be specific, it is one of the more common flavones. From preliminary research, it is thought to play a role in the human body possibly as an antioxidant, a free radical scavenger, a promoter of carbohydrate metabolism, or an immune...
reduces IL-6 production in some neurons.